The ASTRABRAIN is a Humanoid humanoid robot developed by Galbot. The ASTRABRAIN is prototype.
Primary use case: 服务千行百业、千家万户
Locomotion
bipedal
Hand Type
dexterous
Autonomy Level
unknown
AI Capabilities
具身大模型, AstraBrain-WAM通用大脑, AstraBrain-WBC通用小脑, AstraBrain-Dex灵巧手控制, 实时决策, 全身端到端控制
Availability
prototype
Primary Use Case
服务千行百业、千家万户
Figure AI released Helix 2.5, achieving a 56% zero-shot generalization success rate across 30 unseen homes—a leap from 9%—using its Index dataset of 16 million videos and a new scaling approach. Domestic competitors like Unitree, Agibot, and Galaxy Universal are responding with their own data scaling curves, third-party rankings, and specific application deepens, with Wang Xingxing proposing an 80% threshold as the industry explosion point within 2-10 years.
Unitree reported third-quarter 2026 revenue of 665 million yuan, up 69.93%, while net profit fell 17.37% and R&D spending rose 249.58%. AgiBot launched the AGIBOT G2 Max, PIA Automation completed a 1.025 billion yuan STAR Market placement, and CASBOT and MoSense closed new funding rounds. XPeng received citywide Guangzhou Level 4 robotaxi demonstration approval, while Xiaomi disclosed a 21-degree-of-freedom bionic factory hand with 26 motors and 1,500-point tactile sensing.
Unitree Robotics' stock surged more than 30% over three trading sessions (Oct. 16-20), adding nearly 40 billion yuan in market value to reach 212.8 billion yuan, driven by supportive policy, the first six national standards for humanoid robots, and the upcoming World Physical AI Conference. However, the stock now trades at a trailing P/E of 388.25x—far above the industry average of 39.51x—with H1 2026 non-GAAP net profit down 19.34% YoY and industrial/commercial applications accounting for less than 10% of revenue, prompting Bank of America to assign an Underperform rating. The company's first post-IPO quarterly report on Oct. 29 will be a critical valuation test, while Agibot overtook Unitree for the global No. 1 spot in humanoid robot unit shipments in H1 2026.